These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2149161

  • 1. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R, Gloster ES, Altura BT, Altura BM.
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [Abstract] [Full Text] [Related]

  • 2. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R, Altura BT, Altura BM.
    Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910
    [Abstract] [Full Text] [Related]

  • 3. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 4. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.
    Cardiovasc Ther; 2010 Mar; 28(1):23-9. PubMed ID: 20074256
    [Abstract] [Full Text] [Related]

  • 5. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 6. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T, Kanda T, Imai S, Suzuki T, Kobayashi I, Nagai R.
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
    [Abstract] [Full Text] [Related]

  • 7. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
    Guzowski DE, Salgado ED.
    Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
    [Abstract] [Full Text] [Related]

  • 8. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ, Olson JW, Gillespie MN.
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [Abstract] [Full Text] [Related]

  • 9. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 10. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Dec; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 11. Magnesium aspartate hydrochloride attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Mathew R, Gloster ES, Altura BT, Altura BM.
    Clin Sci (Lond); 1988 Dec; 75(6):661-7. PubMed ID: 2974771
    [Abstract] [Full Text] [Related]

  • 12. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
    Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, Rabinovitch M.
    Lab Invest; 1988 Feb; 58(2):184-95. PubMed ID: 3123799
    [Abstract] [Full Text] [Related]

  • 13. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989 Feb; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 14. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U, Olson JW, Gillespie MN.
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [Abstract] [Full Text] [Related]

  • 15. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.
    J Androl; 2009 Nov; 30(5):495-504. PubMed ID: 19201699
    [Abstract] [Full Text] [Related]

  • 16. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat.
    Kawaguchi AT, Kawashima Y, Ishibashi-Ueda H, Mizuta T, Kitoh Y, Kunieda T.
    J Heart Lung Transplant; 1993 Nov; 12(2):325-8; discussion 328-9. PubMed ID: 8476905
    [Abstract] [Full Text] [Related]

  • 17. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L, Zhou TF, Liu HM, Li M, Dou H, Tang ZH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
    [Abstract] [Full Text] [Related]

  • 18. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Mitani Y, Maruyama K, Sakurai M.
    Circulation; 1997 Jul 15; 96(2):689-97. PubMed ID: 9244244
    [Abstract] [Full Text] [Related]

  • 19. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
    Nakashima M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar 15; 21(3):227-39. PubMed ID: 6415328
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan 15; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.